Ono Pharmaceutical Co., Ltd.
OPHLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5,328,189 | $725,154,084 | $739,298,722 | $771,888,668 |
| - Cash | $1,232,759 | $138,991,000 | $204,567,000 | $160,982,000 |
| + Debt | $883,062 | $138,111,000 | $146,678,000 | $154,286,000 |
| Enterprise Value | $4,978,492 | $724,274,084 | $681,409,722 | $765,192,668 |
| Revenue | $878,812 | $127,536,000 | $112,309,000 | $134,223,000 |
| % Growth | -99.3% | 13.6% | -16.3% | – |
| Gross Profit | $641,729 | $90,523,000 | $67,072,000 | $88,387,000 |
| % Margin | 73% | 71% | 59.7% | 65.9% |
| EBITDA | $271,672 | $31,233,000 | -$5,788,000 | $24,045,000 |
| % Margin | 30.9% | 24.5% | -5.2% | 17.9% |
| Net Income | $152,565 | $17,673,000 | -$6,545,000 | $14,951,000 |
| % Margin | 17.4% | 13.9% | -5.8% | 11.1% |
| EPS Diluted | 0.11 | 12.53 | -4.66 | 10.6 |
| % Growth | -99.1% | 368.9% | -144% | – |
| Operating Cash Flow | $352,690 | $3,373,000 | $38,996,000 | $63,047 |
| Capital Expenditures | -$11,374 | -$2,250,000 | -$1,421,000 | -$8,376 |
| Free Cash Flow | $341,316 | $1,123,000 | $37,575,000 | $54,671 |